Royle JG, et al. - Experts evaluated the incidence, prevalence, and survival of systemic sclerosis in the United Kingdom. Findings suggested higher estimates of incidence and prevalence vs previously reported in the UK, but these estimates were similar to recent USA and Swedish studies. A north-south gradient of the occurrence of systemic sclerosis in Europe was not supported. In 20 years’ time, a 24% increase in incident cases and 26% increase in prevalent cases were predicted due to the estimated growth and aging of the population.